Clinical Trial: Evaluation of the efficacy and safety of Edaravone Dexborneol in Acute Ischemic Stroke from Branch Atheromatous Disease: a multicenter, randomized, double-blind, placebo-controlled clinical study (China)

China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of the efficacy and safety of Edaravone Dexborneol in Acute Ischemic Stroke from Branch Atheromatous Disease: a multicenter, randomized, double-blind, placebo-controlled clinical study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132225

Registration Time: 2026/09/10

Type: Interventional study

Primary Sponsor: The First People's Hospital of Foshan

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=329864

Published by HT Digital Content Services with permission from Health Daily Digest....